4 Practical Layout Boundaries for Printing Sunscreen SPF Values: Where Printers Most Often Fail When FDA Regulates Sunscreens as OTC Drugs

For most sunscreen orders received by Chinese printers, the customer supplies a conventional cosmetic label layout with a main display panel, net content, ingredient list, an SPF value, and a small line stating that the product is waterproof or lightweight. Printing to this layout usually allows the goods to clear customs. However, as soon as a sunscreen makes any of the following claims—broad-spectrum protection, SPF ≥ 15, or water resistance for more than 40 minutes—it is no longer treated as a cosmetic by the FDA in the United States. It is regulated as an OTC drug.

In September 2026, a customer approached us with an urgent order. A skincare OEM from Jiangsu needed to send 30,000 bottles of SPF 50+ sunscreen to an Amazon warehouse in the United States before Singles’ Day. The approved artwork had already been used to print 6,000 bottles when the customer’s representative informed the customer that the product was an OTC drug and lacked a Drug Facts panel. The 6,000 gift boxes had to be discarded and reprinted, resulting in a direct loss of CNY 90,000. The remaining 42,000 gift boxes also required revised artwork. As the printer, we had failed to check the Drug Facts box, and the customer asked us to share 30% of the loss.

FDA Treatment of Sunscreens as OTC Drugs Under 21 CFR 201.327

FDA 21 CFR 201.327 states that sunscreen products with an SPF value of 15 or higher and broad-spectrum protection claims are considered over-the-counter drugs. In practical terms, a product with SPF ≥ 15 that claims broad-spectrum protection falls within the OTC drug category. This requirement directly challenges the common assumption among Chinese printers that sunscreen is always a cosmetic.

An OTC drug sold in the United States needs 4 packaging elements that are generally absent from conventional cosmetic labels: the SPF value with the corresponding protection claim, a Drug Facts panel, a minimum warning-statement height, and the correct order of active ingredients in the INCI list. If any element is missing or noncompliant, the FDA may require a recall through Amazon. The importer bears the recall costs, while the printer’s liability depends on the contract.

Layout Boundary 1: How to Present SPF and PA Claims for the US Market

A common presentation in Chinese customer artwork is SPF 50+ PA+++. This format can be used for its intended market, but a US version must retain the SPF value and replace the PA classification with the FDA-recognized wording Broad Spectrum SPF 50+. The FDA does not recognize the PA classification because it originated under the Japanese COSMETIC standard. Printing SPF 50+ PA++++ without an FDA-recognized broad-spectrum claim may prevent the product from entering the US market.

A Zhejiang OEM exported sunscreen to the United States with SPF 50+ PA++++ printed on the label. Customs returned 23,000 bottles because the PA classification is not defined in the US sunscreen monograph under 21 CFR 352. This type of rejection affects approximately 8-12 Chinese export brands each year.

The practical boundary for printers is to identify this issue during file preflight and tell the customer that the US artwork must include Broad Spectrum and that PA should be removed. If the customer insists on printing the full PA classification, note on the shipping document that the customer has confirmed the complete artwork and assumes responsibility for FDA compliance. This record is essential when allocating responsibility for recall losses.

Layout Boundary 2: Drug Facts Type Size and Placement

The Drug Facts panel of an OTC drug is subject to 5 mandatory requirements:

• The border width must be ≥ 0.5 pt, and text inside the panel must be ≥ 1.5 mm from the border under FDA 21 CFR 201.66.
• The Drug Facts heading must be at least 9.5 pt, producing a printed height of approximately 1.7 mm.
• The Active Ingredients section must appear before the Inactive Ingredients section.
• The Uses section must use FDA-standard wording, such as helps prevent sunburn and if used as directed with other sun protection measures.
• The Warnings section must be separate, with For external use only appearing on the first line.

A frequent violation in Chinese cosmetic artwork is a Drug Facts heading printed at 7 pt, producing a height of approximately 1.2 mm. FDA measurements identify 1.5 mm as the rejection threshold. Another common error is placing Avoid contact with eyes on the first line of the Warnings section instead of For external use only. After Amazon identifies bottles with either error in a US warehouse, the platform marks the product as suppressed and removes the listing rather than issuing a recall. Because the goods are already in transit, the financial loss has already occurred.

Layout Boundary 3: SPF Type Size and Label Area

Cosmetic labeling rules do not impose a strict minimum type size for the SPF value. However, 21 CFR 201.327 requires the SPF value to be prominent. During inspections, the FDA applies a visible-at-arm’s-length-reading-distance standard, which generally corresponds to a practical minimum of approximately 9 pt.

Real-world example: a small customer in Guangzhou exported sunscreen in 50 mL bottles. The artwork placed SPF 50+ in 14 pt, approximately 5 mm high, in the most prominent position on the front of the bottle. The FDA inspector raised no objection because 9 pt is a minimum threshold rather than an optimal target. The same customer’s 30 mL travel version had a bottle circumference of 9.5 cm and a 5 cm-wide wrap-around label. It printed SPF 50+ at 6 pt, approximately 2 mm high. The FDA inspector marked it as prominence fails and required the customer to reprint the label.

During file preflight, printers should recommend using raised hot foil or reversed-out lettering for the SPF value on bottles below 30 mL, occupying at least 3% of the label area. Bottles of 50 mL or more may use process printing at 9-14 pt.

Layout Boundary 4: Mandatory Placement of the For external use only Warning

The statement For external use only must appear on a separate line at the top of the Warnings section. Its type size must be no smaller than the Drug Facts heading at 9.5 pt.

A frequent mistake occurs when the customer places this statement below Do not use on broken skin, joining the 2 warnings into one paragraph. Although the layout may appear acceptable, the FDA treats this as a failure of prominence for the warning statement. Approximately 30% of recall cases involve this error.

The practical printer solution is to use a vector-based PDF comparison during file preflight, capture the position of For external use only, and mark with a red arrow that it must be the first line in the Warnings section. Archive the email as evidence that the printer notified the customer before production.

3 Practical Scripts for Printers

Script 1: During file preflight, explain: For orders exported to the United States, products with SPF ≥ 15 and broad-spectrum claims are OTC drugs and require a Drug Facts panel. If the customer does not accept this addition, we recommend printing Only for export to non-US markets or identifying the destination country on the bottle.

Script 2: When recommending a solution, explain: Bottles below 20 mL are not recommended for export to the United States because FDA inspectors apply stricter practical prominence assessments to labels on small containers. Bottles of 30 mL or more can generally accommodate a compliant Drug Facts panel.

Script 3: When allocating risk, state: If the customer does not adopt the printer’s preflight advice, note on the shipping document that the customer has confirmed the complete artwork, assumes responsibility for FDA compliance, and holds the printer responsible only for printing quality.

Further Reading

• 3 Compliance Checks for Packaging Exported to the United States: FDA, Prop 65, and CPSIA
• 4 EU Compliance Requirements for Cosmetic Packaging: REACH / EC 1223/2009 / 94/62/EC / EN 13427
• 4 Standards for Cosmetic Labeling and the Most Common Batch Number Visibility Problem
• 3 Areas of Tightening Cosmetic Packaging Regulation: Cosmetic Supervision Regulations, Children’s Cosmetics, and Labeling Measures